Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Fillit

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Should older adults be screened for dementia? It is important to screen for evidence of dementia!J Wesson Ashford, Soo Borson, Ruth O'Hara, et al.
JAMA|June 24, 2004
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory StudySally A Shumaker, Claudine Legault, Lewis Kuller, et al.
Journal of the American Geriatrics Society|July 22, 2008
A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory StudyKaren C Johnson, Karen L Margolis, Mark A Espeland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2010
Dependence as a unifying construct in defining Alzheimer's disease severityTrent McLaughlin, Howard Feldman, Howard Fillit, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementiaDawn C Matthews, Aaron Ritter, Ronald G Thomas, et al.
Journal of the American Geriatrics Society|February 4, 2015
Findings from the National Memory Screening Day programPeter J Bayley, Jennifer Y Kong, Marta Mendiondo, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundationJeffrey Cummings, Michael Gold, Mark Mintun, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 25, 2004
Biomarkers of aging: from primitive organisms to humansRobert N Butler, Richard Sprott, Huber Warner, et al.
Journal of Internal Medicine|May 24, 2025
Implementing early detection of cognitive impairment in primary care to improve care for older adultsNicole R Fowler, Katherine A Partrick, James Taylor, et al.
Alzheimer'S Research & Therapy|March 4, 2020
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's diseaseMartí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Should older adults be screened for dementia? It is important to screen for evidence of dementia!J Wesson Ashford, Soo Borson, Ruth O'Hara, et al.
JAMA|June 24, 2004
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory StudySally A Shumaker, Claudine Legault, Lewis Kuller, et al.
Journal of the American Geriatrics Society|July 22, 2008
A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory StudyKaren C Johnson, Karen L Margolis, Mark A Espeland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2010
Dependence as a unifying construct in defining Alzheimer's disease severityTrent McLaughlin, Howard Feldman, Howard Fillit, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementiaDawn C Matthews, Aaron Ritter, Ronald G Thomas, et al.
Journal of the American Geriatrics Society|February 4, 2015
Findings from the National Memory Screening Day programPeter J Bayley, Jennifer Y Kong, Marta Mendiondo, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundationJeffrey Cummings, Michael Gold, Mark Mintun, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 25, 2004
Biomarkers of aging: from primitive organisms to humansRobert N Butler, Richard Sprott, Huber Warner, et al.
Journal of Internal Medicine|May 24, 2025
Implementing early detection of cognitive impairment in primary care to improve care for older adultsNicole R Fowler, Katherine A Partrick, James Taylor, et al.
Alzheimer'S Research & Therapy|March 4, 2020
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's diseaseMartí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, et al.
Pageof 8